Skip to main content
. 2019 May 30;11:4947–4956. doi: 10.2147/CMAR.S202268

Figure 4.

Kaplan–Meier survival analyses based on nuclear GAPDH and HIF-1α expression in HCC patients. (A) The OS of postoperative HCC patients with low/high nuclear GAPDH expression. (B) The TTR of postoperative HCC patients with low/high nuclear GAPDH expression. (C) The OS of postoperative HCC patients with low/high HIF-1α expression. (D) The TTR of postoperative HCC patients with low/high HIF-1α expression. (E) The OS of postoperative HCC patients based on both nuclear GAPDH and HIF-1α expression. (F) The TTR of postoperative HCC patients based on both nuclear GAPDH and HIF-1α expression.

Note: *p<0.05 is considered significantly different.

Abbreviations: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HIF-1α, hypoxia-inducible factor 1α; OS, overall survival; TTR, time to recurrence; HCC, hepatocellular carcinoma.

Figure 4